Ursprung des Netzwerks ersten Grades von Stephen Kilmer
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephen Kilmer
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Medical Specialties | Director/Board Member | |
| ELINE ENTERTAINMEN | Movies/Entertainment | Director of Finance/CFO | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| STEMLINE THERAPEUTICS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| OKYO PHARMA LIMITED | Biotechnology | Director/Board Member | |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| THERALASE TECHNOLOGIES INC. | Medical Specialties | Director/Board Member | |
| Concordia University | College/University | Graduate Degree | |
| Iona College | College/University | Undergraduate Degree | |
| University of Alberta | College/University | Doctorate Degree | |
| Seton Hall University | College/University | Undergraduate Degree Masters Business Admin | |
| University of Windsor | College/University | Doctorate Degree | |
Orchestra Medical Ventures LLC
 Orchestra Medical Ventures LLC Investment ManagersFinance Orchestra Medical Ventures LLC (Orchestra Medical Ventures) is a venture capital firm founded in 2001 by Richard P. Geoffrion and Yuval Binur. The firm is headquartered in New Hope, Pennsylvania. | Investment Managers | Director of Finance/CFO | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Director/Board Member | |
| ESSEC Business School | College/University | Graduate Degree | |
Accelerated Technologies, Inc.
 Accelerated Technologies, Inc. Medical DistributorsDistribution Services Accelerated Technologies, Inc. creates and accelerates cardiovascular medical devices. The company was founded by Martin B. Leon and Yuval Binur and is headquartered in Hackensack, NJ. | Medical Distributors | Director of Finance/CFO | |
| Vantage Health System, Inc. | Director/Board Member | ||
| Hepatitis B Foundation | Founder | ||
| Mohammed V University | College/University | Doctorate Degree | |
| Drexel University College of Medicine | College/University | Corporate Officer/Principal | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Pennsylvania Biotechnology Center of Bucks County | Chief Executive Officer | ||
| Baruch S. Blumberg Institute | Founder | ||
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Equipment/Instruments | Director/Board Member | |
| ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Founder | |
Steba Biotech SA
 Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Steba Biotech SA is a Luxembourger biotechnology company that focuses on developing therapies to combat cancer. The private company is based in Luxembourg, Luxembourg. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Biotechnology | Corporate Officer/Principal | |
| ACCUSTEM SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 27 |
| Kanada | 6 |
| Vereinigtes Königreich | 3 |
| Hong Kong | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Finance | 3 |
| Retail Trade | 2 |
Operativ
| Director/Board Member | 17 |
| Independent Dir/Board Member | 11 |
| Director of Finance/CFO | 5 |
| Corporate Officer/Principal | 5 |
| Founder | 4 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John Brancaccio | 17 |
| Timothy Block | 8 |
| Kaouthar Lbiati | 8 |
| John Cavan | 7 |
| Daren Ure | 3 |
| Daniel Trepanier | 3 |
- Börse
- Insiders
- Stephen Kilmer
- Unternehmensverbindungen
